Following the news that Category M adjustments will occur from August 2024, Malcolm Harrison, Chief Executive of the CCA said:
“At a time when finances for community pharmacy are exceptionally tight, further clawbacks will only serve to place additional strain on pharmacies’ cashflow.
The cycle of adjustments and clawbacks demonstrates the need to urgently review the system of retained margin.
The level of retained margin available to pharmacies, for procuring medicines for the NHS has not been increased since 2014, despite a decade of increases to both the volume and cost of prescribed medicines”.